Valuation: Sartorius Stedim Biotech SA

Market Cap 21.07B 23.96B 19.93B 18.08B 33.97B 2,300B 34.15B 238B 92.1B 1,174B 89.93B 87.99B 3,772B P/E 2026 *
55.5x
P/E 2027 * 42.9x
Enterprise Value 23.08B 26.25B 21.84B 19.8B 37.21B 2,520B 37.41B 261B 101B 1,286B 98.51B 96.38B 4,132B EV / Sales 2026 *
7.38x
EV / Sales 2027 * 6.58x
Free-Float
28.47%
Yield 2026 *
0.38%
Yield 2027 * 0.47%
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%-1.59%-24.39%+5.71% 175B
+0.97%-2.85%-5.01%+14.42% 113B
-1.01%-1.61%-1.04%+64.08% 58.57B
+0.01%+1.60%-0.42%-28.97% 50.07B
+0.45%+4.36%+15.64%+53.13% 49.92B
+0.07%-2.99%+29.18%-5.87% 32.69B
+1.07%+10.84% - - 30.44B
+1.41%+3.68%+43.64%+0.13% 26.07B
+1.98%+9.34%+26.26%-2.43% 23.55B
Average +0.38%+1.76%+10.48%+12.52% 62.22B
Weighted average by Cap. -0.00%+0.01%-2.71%+13.87%

Financials

2026 *2027 *
Net sales 3.13B 3.56B 2.96B 2.68B 5.04B 341B 5.07B 35.39B 13.67B 174B 13.35B 13.06B 560B 3.47B 3.95B 3.28B 2.98B 5.6B 379B 5.63B 39.28B 15.17B 193B 14.81B 14.49B 621B
Net income 378M 430M 358M 324M 610M 41.28B 613M 4.28B 1.65B 21.07B 1.61B 1.58B 67.7B 482M 548M 456M 413M 777M 52.59B 781M 5.45B 2.11B 26.84B 2.06B 2.01B 86.25B
Net Debt 2.01B 2.29B 1.9B 1.72B 3.24B 219B 3.26B 22.75B 8.78B 112B 8.58B 8.39B 360B 1.76B 2.01B 1.67B 1.51B 2.84B 192B 2.86B 19.96B 7.71B 98.23B 7.53B 7.36B 316B
Logo Sartorius Stedim Biotech SA
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-